Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Zhejiang Hisun Biomaterials Co's Revenue for the
three
months ended in Mar. 2026 was ¥267.6 Mil. Zhejiang Hisun Biomaterials Co's average Accounts Receivable for the
three
months ended in Mar. 2026 was ¥67.0 Mil.
Hence, Zhejiang Hisun Biomaterials Co's Receivables Turnover for the
three
months ended in Mar. 2026 was 3.99.
Zhejiang Hisun Biomaterials Co (SHSE:688203) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Zhejiang Hisun Biomaterials Co Receivables Turnover Related Terms
Zhejiang Hisun Biomaterials Co Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Hisun Biomaterials Co Receivables Turnover Chart
SHSE:688203 vs DOW: Receivables Turnover Comparison
For the Chemicals subindustry, Zhejiang Hisun Biomaterials Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Hisun Biomaterials Co Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Zhejiang Hisun Biomaterials Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Zhejiang Hisun Biomaterials Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Hisun Biomaterials Co (SHSE:688203) has a Receivables Turnover of 3.99 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Zhejiang Hisun Biomaterials Co and its competitors. According to the industry distribution chart, Zhejiang Hisun Biomaterials Co ranks #181 out of 1581 companies in the Chemicals industry, placing it in the top 11.4%.
Is Zhejiang Hisun Biomaterials Co's Receivables Turnover too high?
Zhejiang Hisun Biomaterials Co's current Receivables Turnover is 3.99. The Chemicals industry median Receivables Turnover is 5.65. Zhejiang Hisun Biomaterials Co's value of 3.99 is 29.4% below this industry median. Based on the distribution chart, Zhejiang Hisun Biomaterials Co ranks #181 out of 1581 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Hisun Biomaterials Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Hisun Biomaterials Co's Receivables Turnover compare to DOW?
According to the Chemicals industry distribution chart, Zhejiang Hisun Biomaterials Co ranks #181 out of 1581 companies for Receivables Turnover. This places Zhejiang Hisun Biomaterials Co in the top 11% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.65. Zhejiang Hisun Biomaterials Co's value of 3.99 is 29.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.65, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Hisun Biomaterials Co's current Receivables Turnover of 3.99 is 29.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Zhejiang Hisun Biomaterials Co and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Hisun Biomaterials Co's current Receivables Turnover is 3.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Hisun Biomaterials Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Hisun Biomaterials Co (SHSE:688203) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.02, compared to a current price of ¥11.56 — trading 17.5% below its estimated fair value. The current Receivables Turnover is 3.99 and 29.4% below the Chemicals industry median of 5.65. Zhejiang Hisun Biomaterials Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Zhejiang Hisun Biomaterials Co (SHSE:688203), the current Receivables Turnover is 3.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Hisun Biomaterials Co (SHSE:688203) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Hisun Biomaterials Co stock appears to be undervalued.
The current stock price of ¥11.56 is trading 17.5% below its estimated GF Value™ of ¥14.02.
GuruFocus considers Zhejiang Hisun Biomaterials Co to be Modestly Undervalued.
Key valuation signals for SHSE:688203:
Receivables Turnover: 3.99
GF Value™: ¥14.02 vs. price of ¥11.56 (17.5% below fair value)
Industry Position: 29.4% below the Chemicals median (#181 of 1581)
No single metric tells the full story. See the SHSE:688203 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688203 has been successfully added to your 
